Xiaoli Cheng
8Patents
6h-index
19Co-inventors
52Inventor score
Filing activity: Jul 15, 2015 → Nov 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9624268B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 26 | Active |
| US10035824B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 19 | Active |
| US10023614B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 19 | Active |
| US10196424B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 17 | Active |
| US10787490B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Human Necessities | 13 | Active |
| US10941183B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 8 | Active |
| US11939361B2 | Compositions of peptide inhibitors of Interleukin-23 receptor | Human Necessities | 0 | Active |
| US11884748B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.